ProPhase Labs, Inc. (NAS: PRPH) Stock Analysis & Fundamentals

PRPHProPhase Labs, Inc.

NAS · US · Healthcare · Diagnostics & Research · prophaselabs.com

0.0291USD-3.00%Mkt Cap: 407871 $P/E: —2d ago

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a ra…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

IDEXX Laboratories, Inc.

$44.35BUSDP/E 39.5

Agilent Technologies, Inc.

Mettler-Toledo International, Inc.

$28.55BUSDP/E 32.1

Labcorp Holdings Inc.

$26.80BUSDP/E 27.4

DGX

Quest Diagnostics Incorporated

$26.68BUSDP/E 25.6

Guardant Health, Inc.

$21.92BUSD

MEDP

Medpace Holdings, Inc.

$16.98BUSDP/E 35.8

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$13.84BUSD

RVTY

Revvity Inc. Common Stock

Key Statistics

Company

Market Cap407.87K $

Enterprise Value—

Revenue (TTM)—

Gross Profit1.38M $

Net Income (TTM)-14.74M $

Revenue/Share0.5120 USD

Last Price0.0291 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees19

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)0.06

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.68

EPS (TTM)-1.85

EPS (Forward)0.48

52W Range

0.02800% of range6.700

52W High6.700 USD

52W Low0.0280 USD

Profitability

Gross Margin31.85%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin-339.31%

ROE-420.27%

ROA-24.62%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.34M $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity2.46

Current Ratio—

Quick Ratio—

Book Value/Sh-0.0440 USD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateMay 24, 2022

Pay DateJun 3, 2022

Splits

Last Split1:10

Split DateDec 22, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.14.02M

Float—

Insiders2.13%

Institutions0.06%

Short Interest

Short Ratio0.1d

Short % Float0.71%

Short % Out.0.65%

Shares Short30.02K

Short (prev mo.)8.96K

Technical

SMA 500.0662 (-56.0%)

SMA 2000.4473 (-93.5%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)77.61K

Avg Vol (10d)431.72K

Technical Indicators

RSI (14)34.3

MACD-0.0097

MACD Signal-0.0095

MACD Hist.-0.0002

BB Upper0.0695 USD

BB Middle0.0473 USD

BB Lower0.0250 USD

BB Width94.11%

ATR (14)0.0105 USD

Vol Ratio (20d)3.25x